Silicone-induced granulomas and renal failure

Dialysis and Transplantation

Volumn 39, Issue 6, 2010, Pages 254-259

  Khan, Omer ^a   Sim, John J ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CEFAZOLIN; CREATININE; GALLIUM 67; PARATHYROID HORMONE; PREDNISONE; SILICONE; SODIUM CHLORIDE;

ABDOMINAL PAIN; ADULT; ARTICLE; BREAST AUGMENTATION; CASE REPORT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSURIA; ESCHERICHIA COLI INFECTION; ESTHETIC SURGERY; FEVER; FLANK PAIN; GRANULOMA; GRANULOMATOSIS; HEMODIALYSIS; HIP RADIOGRAPHY; HUMAN; HYPERCALCEMIA; HYPERPIGMENTATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; LOW DRUG DOSE; MALAISE; MALE; MALE TO FEMALE TRANSSEXUAL; NEPHROLITHIASIS; NEPHROSTOMY; ORCHIECTOMY; PARATHYROID HORMONE BLOOD LEVEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENOGRAPHY; SILICONE INDUCED GRANULOMA; SKIN BIOPSY; THIRST; UNSPECIFIED SIDE EFFECT; UREMIA; URETER STENT; URINARY TRACT INFECTION; UROLITHIASIS; VITAMIN BLOOD LEVEL;

EID: 77953885129     PISSN: 00902934     EISSN: 19326920     Source Type: Journal    
DOI: 10.1002/dat.20448     Document Type: Article

References (35)

1. Rapaport M. Silicone injections revisited. Dermatol Surg. 2002;28(7):594-595.
2. Rapaport MJ. Silicone granulomas treated with etanercept. Arch Dermatol. 2005;141(9):1171.
3. Schwartzfarb EM, Hametti JM, Romanelli P, Ricotti C. Foreign body granuloma formation secondary to silicone injection. Dermatol Online J. 2008;14(7):20.
4. Bigata X, Ribera M, Bielsa I, Ferrandiz C. Adverse granulomatous reaction after cosmetic dermal silicone injection. Dermatol Surg. 2001;27(2):198-200.
5. Wilkie TF. Late development of granuloma after liquid silicone injections. Plast Reconstr Surg. 1977;60(2):179-188.
6. Busch H. Silicone toxicology. Semin Arthritis Rheum. 1994;24(suppl 1):11-17.
7. Hage JJ, Kanhai RC, Oen AL, van Diest PJ, Karim RB. The devastating outcome of massive subcutaneous injection of highly viscous fluids in maleto-female transsexuals. Plast Reconstr Surg. 2001;107(3):734-741.
8. Kozeny GA, Barbato AL, Bansal VK, Vertuno LL, Hano JE. Hypercalcemia associated with silicone-induced granulomas. N Engl J Med. 1984;311(17):1103- 1105.
9. Price EA, Schueler H, Perper JA. Massive systemic silicone embolism: a case report and review of literature. Am J Forensic Med Pathol. 2006;27(2):97-102.
10. Duffy DM. Silicone: a critical review. Adv Dermatol. 1990;5:93-107; discussion 108-109.
11. Orentreich DS, Orentreich N. Injectable fluid silicone. In: Roenigk R, Roenigk H, eds. Dermatologic Surgery: Principals and Practice. New York, NY: Marcel Dekker; 1989.
12. Polak S. Silicone, fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol. 1990;16:957-996.
13. Webster RC, Gaunt JM, Hamdan US, Fuleihan NS, Smith RC. Injectable silicone for facial soft-tissue augmentation. Arch Otolaryngol Head Neck Surg. 1986;112(3):290-296.
14. Orentreich DS. Liquid injectable silicone: techniques for soft tissue augmentation. Clin Plast Surg. 2000;27(4):595-612.
15. Alkek DS. Lip augmentation with silicone. J Dermatol Surg Oncol. 1991;17(9):747-748.
16. Orentreich N, Durr NP. The four R's of skin rehabilitation. In: Grahan J, Kligman A, eds. The Psychology of Cosmetic Treatments. New York, NY: Praeger; 1985.
17. Hexsel DM, Hexsel CL, Iyengar V. Liquid injectable silicone: history, mechanism of action, indications, technique, and complications. Semin Cutan Med Surg. 2003;22(2):107-114.
18. Duffy DM. The silicone conundrum: a battle of anecdotes. Dermatol Surg. 2002;28(7):590-594.
19. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med. 1981;305(8):440-443. (Pubitemid 11047046)
20. Adams JS, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983;72(5):1856-1860. (Pubitemid 14229067)
21. Adams JS, Singer FR, Gacad MA, et al. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab. 1985;60(5):960-966.
22. Mason RS, Frankel T, Chan YL, Lissner D, Posen S. Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med. 1984;100(1):59-61. (Pubitemid 14219130)
23. Inui N, Murayama A, Sasaki S, et al. Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. Am J Med. 2001;110(9):687-693.
24. Dusso AS, Kamimura S, Gallieni M, et al. gammainterferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab. 1997;82(7):2222-2232.
25. Shaker JL, Redlin KC, Warren GV, Findling JW. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis. Am J Med Sci. 1994;308(2):115-118. (Pubitemid 24309316)
26. Falk S, Kratzsch J, Paschke R, Koch CA. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Med Sci Monit. 2007;13(11):CS133-136.
27. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med. 1989;111(5):437-438.
28. DeSimone DP, Brilliant HL, Basile J, Bell NH. Granulomatous infiltration of the talus and abnormal vitamin D and calcium metabolism in a patient with sarcoidosis: successful treatment with hydroxychloroquine. Am J Med. 1989;87(6):694-696.
29. Adams JS, Sharma OP, Diz MM, Endres DB. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab. 1990;70(4):1090-1095. (Pubitemid 120020139)
30. Al-Ali H, Yabis AA, Issa E, et al. Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. Bone. 2002;30(1):331-334.
31. Sandler LM, Winearls CG, Fraher LJ, Clemens TL, Smith R, O'Riordan JL. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med. 1984;53(210):165-180.
32. O'Leary TJ, Jones G, Yip A, Lohnes D, Cohanim M, Yendt ER. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med. 1986;315(12):727-730.
33. Barre PE, Gascon-Barre M, Meakins JL, Goltzman D. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med. 1987;82(6):1259-1262.
34. Pasternack FR, Fox LP, Engler DE. Silicone granulomas treated with etanercept. Arch Dermatol. 2005;141(1):13-15.
35. Utz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003;124(1):177-185.